Clinical Trial Update: A Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AG-181 in Subjects With Phenylketonuria [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial to assess safety, tolerability, pharmacokinetics, and pharmacodynamics of AG-181 in subjects with phenylketonuria, currently recruiting…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Phenylketonuria

Drugs mentioned

• AG-181

Snippet

Sponsor: Agios Pharmaceuticals, Inc. | Conditions: Phenylketonuria | Phase 1 | Status: RECRUITING